Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-025217
Filing Date
2013-05-09
Accepted
2013-05-09 16:21:06
Documents
1
Period of Report
2013-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5848
  Complete submission text file 0001209191-13-025217.txt   7257
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 14 WYNNWOOD RD GREENWICH CT 06830-3409
Business Address
HARTLEY C KEITH (Reporting) CIK: 0001192994 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 13829189